An Open Drug Discovery Competition: Experimental Validation of Predictive Models in a Series of Novel Antimalarials
Open Access
- 8 November 2021
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 64 (22) , 16450-16463
Abstract
The Open Source Malaria (OSM) consortium is developing compounds that kill the human malaria parasite, Plasmodium falciparum, by targeting PfATP4, an essential ion pump on the parasite surface. The structure of PfATP4 has not been determined. Here, we describe a public competition created to develop a predictive model for the identification of PfATP4 inhibitors, thereby reducing project costs associated with the synthesis of inactive compounds. Competition participants could see all entries as they were submitted. In the final round, featuring private sector entrants specializing in machine learning methods, the best-performing models were used to predict novel inhibitors, of which several were synthesized and evaluated against the parasite. Half possessed biological activity, with one featuring a motif that the human chemists familiar with this series would have dismissed as “ill-advised”. Since all data and participant interactions remain in the public domain, this research project “lives” and may be improved by others.Keywords
All Related Versions
Funding Information
- Engineering and Physical Sciences Research Council (EP/L015552/1, EP/L015552/2, EP/S000356/1)
- Royal Society
- Australian Research Council (LP150101226)
- Medicines for Malaria Venture (RD/11/0040)
- University College London
- National Science Foundation (1833181)
This publication has 42 references indexed in Scilit:
- Mycobacterial Dihydrofolate Reductase Inhibitors Identified Using Chemogenomic Methods and In Vitro ValidationPLOS ONE, 2015
- (+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of PlasmodiumProceedings of the National Academy of Sciences, 2014
- Pyrazoleamide compounds are potent antimalarials that target Na+ homeostasis in intraerythrocytic Plasmodium falciparumNature Communications, 2014
- Diverse chemotypes disrupt ion homeostasis in the malaria parasiteMolecular Microbiology, 2014
- Corrected small basis set Hartree‐Fock method for large systemsJournal of Computational Chemistry, 2013
- Crowd computing: using competitive dynamics to develop and refine highly predictive modelsDrug Discovery Today, 2013
- Na+ Regulation in the Malaria Parasite Plasmodium falciparum Involves the Cation ATPase PfATP4 and Is a Target of the Spiroindolone AntimalarialsCell Host & Microbe, 2013
- Spiroindolones, a Potent Compound Class for the Treatment of MalariaScience, 2010
- The Chemistry Development Kit (CDK): An Open-Source Java Library for Chemo- and BioinformaticsJournal of Chemical Information and Computer Sciences, 2003
- A general synthesis of substituted fluorenones and azafluorenonesThe Journal of Organic Chemistry, 1988